Literature DB >> 18314212

Electrospun biodegradable nanofiber nonwovens for controlled release of proteins.

Sascha Maretschek1, Andreas Greiner, Thomas Kissel.   

Abstract

Electrospinning of emulsions composed of an organic poly(l-lactide) solution and an aqueous protein solution yielded protein containing nanofiber nonwovens (NNs) having a mean fiber diameter of approximately 350 nm. Cytochrome C was chosen as a hydrophilic model protein for encapsulation. SEM imaging and gas adsorption measurements were carried out to determine morphology and surface characteristics of the different nanofiber nonwovens. Transmission electron microscopy was used to clarify the localization of the protein within the NN. PLLA NNs exhibited a highly hydrophobic surface which led to a slow wetting. It was shown that the protein release was dependent on the surface tension of the release medium. Electrospinning of emulsions consisting of an organic solution of PLLA and an aqueous solution of hydrophilic polymers yielded fibers composed of a polymer blend. The resulting NNs exhibited a less hydrophobic surface, which gave us the opportunity to tailor the release profile via this technology. Furthermore it was investigated how the addition of different amounts of hydrophilic polymer to the aqueous phase influenced the morphology of the resulting NNs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314212     DOI: 10.1016/j.jconrel.2008.01.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  27 in total

1.  Effect of direct RGD incorporation in PLLA nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells.

Authors:  Markus Dietmar Schofer; Ulrich Boudriot; Sarah Bockelmann; Andreas Walz; Joachim Heinz Wendorff; Andreas Greiner; Jürgen Rudolf Josef Paletta; Susanne Fuchs-Winkelmann
Journal:  J Mater Sci Mater Med       Date:  2009-03-01       Impact factor: 3.896

2.  Generation of multilayered structures for biomedical applications using a novel tri-needle coaxial device and electrohydrodynamic flow.

Authors:  Z Ahmad; H B Zhang; U Farook; M Edirisinghe; E Stride; P Colombo
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

3.  Controlled delivery of fibroblast growth factor-9 from biodegradable poly(ester amide) fibers for building functional neovasculature.

Authors:  Somiraa S Said; J Geoffrey Pickering; Kibret Mequanint
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

Review 4.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

Review 5.  Electrospinning strategies of drug-incorporated nanofibrous mats for wound recovery.

Authors:  Ji Suk Choi; Hye Sung Kim; Hyuk Sang Yoo
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 6.  Reductionist Approach in Peptide-Based Nanotechnology.

Authors:  Ehud Gazit
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

7.  Temperature-responsive electrospun nanofibers for 'on-off' switchable release of dextran.

Authors:  Young-Jin Kim; Mitsuhiro Ebara; Takao Aoyagi
Journal:  Sci Technol Adv Mater       Date:  2012-10-18       Impact factor: 8.090

Review 8.  Nanofibers offer alternative ways to the treatment of skin infections.

Authors:  T D J Heunis; L M T Dicks
Journal:  J Biomed Biotechnol       Date:  2010-07-28

9.  Mechanistic examination of protein release from polymer nanofibers.

Authors:  M Gandhi; R Srikar; A L Yarin; C M Megaridis; R A Gemeinhart
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

Review 10.  Poly(lactic acid) nanofibrous scaffolds for tissue engineering.

Authors:  Marco Santoro; Sarita R Shah; Jennifer L Walker; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2016-04-26       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.